Navigation Links
TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Date:12/10/2007

Final Data from Pivotal Study Presented at 49th American Society of

Hematology Meeting

FRAZER, Pa., Dec. 10 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that in a pivotal study of patients with indolent non-Hodgkin's lymphoma (NHL), whose disease has progressed during or following treatment with rituximab, TREANDA (bendamustine HCl) induced a high rate of response. TREANDA(R) is a novel investigational chemotherapy. According to the National Cancer Institute, an estimated 30,000 people in the United States will be diagnosed in 2007 with indolent NHL, a serious and slow growing cancer of the lymphatic system that is difficult to treat because patients are prone to relapse after treatment. The final data from this multicenter study were presented at the 49th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, GA [Poster # 505-I; Abstract #1351].

"The high response rate in this study suggest that bendamustine could offer substantial periods of remission to patients with indolent NHL whose cancer is progressing after treatment with rituximab," said Brad Kahl, MD, Associate Professor, Director Lymphoma Service, University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, and the lead investigator of this study. "Because many patients with NHL eventually become resistant to treatment with rituximab and other therapies, new treatments are always required."

In this pivotal study of 100 patients with indolent NHL whose disease has progressed during or following treatment with rituximab, or a rituximab- containing regimen, as assessed by an independent radiological committee, 75 patients had a response. Of those patients who responded to treatment, 14 had a complete response and three had an unconfirmed complete response. The median duration of response was 9.2 months. Bendamustine demonstrated a manageable tolerability profile. As would be expected of a chemothera
'/>"/>

SOURCE Cephalon Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
2. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
3. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
4. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
5. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
6. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
7. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
8. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
9. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
10. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
11. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... China Jo-Jo Drugstores, Inc. (NASDAQ ... a leading China-based retail and wholesale distributor that offers ... retail pharmacies, today announced its subsidiary, Hangzhou Jiuzhou Grand ... new sales incentive agreement with Wyeth Pharmaceutical Company, Ltd. ... of Pfizer Inc. (NYSE: PFE ) ...
(Date:4/26/2015)... April 26, 2015  Ikonopedia announced today that ... system have been selected for use by BelleBridge, ... screening and diagnostic examinations. Ikonopedia will showcase its ... of Breast Imaging,s SBI/ACR Breast Imaging Symposium in ... 2015 (SBI Booth #216). BelleBridge is ...
(Date:4/24/2015)... -- Today, humanity takes a massive step toward reaching our ... 1-800 CONTACTS announces their new Apple Watch app which allows ... Two taps. New contacts. From your watch. We ... features LensGauge which helps keep track of how long your ... "Since our inception, we,ve been dedicated to providing ...
Breaking Medicine Technology:China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 2China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 3China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 4Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 2Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 3Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 4Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2
... , May 25 Otix Global, Inc. (Nasdaq: ... has begun offering franchising opportunities to audiologists and audiometrists throughout ... at the annual Audiological Society of Australia (ASA) conference ... to the American Academy of Audiology conference which is held in ...
... CAMPBELL, Calif. , May 25 ... and personalized therapy guidelines for cardiovascular disease.  HNL ... offering an accompanying nutrition program, and wellness coaching. ... appropriate risk characterization and treatment, cardiovascular disease can ...
Cached Medicine Technology:Otix Global to Offer Franchise Opportunities in Australia 2Otix Global to Offer Franchise Opportunities in Australia 3Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program. 2
(Date:4/27/2015)... Scooter Direct is now offering Pride Go Go ... only $929.00, marked down from the MSRP of $1605.00. ... for offering quality mobility solutions to its clients. The ... lift chairs, and their accessories at unbeatable prices. ... Go Traveller Elite, a senior store manager stated, “Electric ...
(Date:4/27/2015)... On the top floor of the luxurious ... beautiful Los Angeles, CA, Per Wickstrom had an in-depth ... Housewives of Orange County” Gretchen Christine Rossi. , ... the “Salute to the Oscars” celebration, sponsored by Choices ... by Wickstrom, Rossi felt that the evening’s interviews would ...
(Date:4/27/2015)... 27, 2015 The WeedLife Network ... a problem that has been troubling cannabis businesses ... by announcing the launch of WeedLIVE, the ... , Officially launched today, WeedLIVE.com is designed ... to index only marijuana-related business websites. , WeedLIVE ...
(Date:4/27/2015)... Pure n Natural Systems, Inc. is pleased to ... at http://www.purennatural.com/ . The new website includes ... featured and sale items, as well as the official ... n Natural Systems’ website is designed to give customers ... neatly organized and provides plenty of useful information to ...
(Date:4/27/2015)... CA (PRWEB) April 27, 2015 PREVENT ... is expanding its Texas operations with the addition of ... provide life safety services to a growing customer base, ... team as a new Senior Account Manager. Curtis has ... and support existing customers throughout the Houston area and ...
Breaking Medicine News(10 mins):Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 2Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 3Health News:Per Wickstrom Shares His Vision of Choices Recovery with Reality TV Star Gretchen Christine Rossi 2Health News:The WeedLife Network debuts its ground-breaking WeedLIVE cannabis industry search engine 2Health News:The WeedLife Network debuts its ground-breaking WeedLIVE cannabis industry search engine 3Health News:Pure n Natural Systems, Inc. Launches New Website Design 2Health News:Pure n Natural Systems, Inc. Launches New Website Design 3Health News:PREVENT Life Safety Services Welcomes Curtis Rice as a New Senior Account Manager in Houston, TX 2
... JOLLA, CA April 14, 2011 An enzyme essential ... way that might be exploited as anti-cancer therapy, say researchers ... The research, published in the April 15, 2011 issue ... group of enzymes called flap endonucleases, which are essential to ...
... Human Vaccine Institute today announced a collaboration and ... enable the rapid development of a vaccine and ... threat such as pandemic influenza. The team, composed ... of the National Institute of Allergy and Infectious ...
... noon ET) The circadian system that controls normal ... brain cells called astrocytes, according to a study published ... a Cell Press publication. Neuroscientists from Tufts University School ... fruit flies (Drosophila) led to altered daily rhythms, an ...
... INDIANAPOLIS With mounting evidence that patient-centered care ... and Indiana University School of Medicine are providing ... future physicians to master relationship skills as well ... 21st Century medicine. "Crossing the ...
... of polluted air appears to activate a protein that ... events that lead to widespread inflammation, according to new ... the gap in researchers, understanding of how prolonged exposure ... and other diseases. The research group, led by ...
... An international consortium of scientists, including major ... the "one-size fits all" strategy of uniformly doubling ... patients with high on-treatment platelet reactivity does not ... stent thrombosis after percutaneous coronary intervention (PCI). The ...
Cached Medicine News:Health News:Study suggests enzyme crucial to DNA replication may provide potent anti-cancer drug target 2Health News:Study suggests enzyme crucial to DNA replication may provide potent anti-cancer drug target 3Health News:Study suggests enzyme crucial to DNA replication may provide potent anti-cancer drug target 4Health News:Duke Human Vaccine Institute signs research agreement to develop pandemic virus vaccines 2Health News:Duke Human Vaccine Institute signs research agreement to develop pandemic virus vaccines 3Health News:Rising star of brain found to regulate circadian rhythms 2Health News:Training future doctors to enlist patients as partners in care 2Health News:Polluted air leads to disease by promoting widespread inflammation 2Health News:Polluted air leads to disease by promoting widespread inflammation 3Health News:Polluted air leads to disease by promoting widespread inflammation 4Health News:Polluted air leads to disease by promoting widespread inflammation 5Health News:Antiplatelets: 1 person, 1 dose? 2
... pressure sensor catheters incorporate a ... injection/guide wire, or high-speed injection/guide ... high-speed injection has two laterally ... an open-end pigtail extension for ...
... These dual pressure sensor ... sampling/slow-speed injection, slow-speed injection/guide wire, ... model SPC-784A for high-speed injection ... side openings and an open-end ...
... Dual Pressure Sensor Intravascular Mikro-Tip ... a line of dual pressure sensor ... measurements. These catheters are suitable for ... between chambers, or across a vascular ...
... dBC is a flat detector biplane ... ideal for cardiological diagnostics and intervention. ... you to optimally adapt the system ... and electrophysiological applications with tableside operation. ...
Medicine Products: